These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 33749864)
1. The evolution of clinical trials in response to COVID-19. Sarah A; Dean O; Berk M Med J Aust; 2021 Apr; 214(7):332-332.e1. PubMed ID: 33749864 [No Abstract] [Full Text] [Related]
2. Not in my backyard: COVID-19 vaccine development requires someone to be infected somewhere. Heriot GS; Jamrozik E Med J Aust; 2021 Mar; 214(4):150-152.e1. PubMed ID: 33550606 [No Abstract] [Full Text] [Related]
3. Inclusion of children and pregnant women in COVID-19 intervention trials. Malhotra A; Kumar A; Roehr CC; den Boer MC Pediatr Res; 2021 Apr; 89(5):1063-1064. PubMed ID: 32688370 [No Abstract] [Full Text] [Related]
4. Ethical and Scientific Considerations Regarding the Early Approval and Deployment of a COVID-19 Vaccine. Dal-Ré R; Caplan AL; Gluud C; Porcher R Ann Intern Med; 2021 Feb; 174(2):258-260. PubMed ID: 33216636 [TBL] [Abstract][Full Text] [Related]
5. Key steps in our journey to a COVID-19 vaccine program. Blyth CC; Flanagan KL; Gibbs RA; Crawford NW; Cheng AC Med J Aust; 2021 Apr; 214(6):249-251.e1. PubMed ID: 33745153 [No Abstract] [Full Text] [Related]
6. Africa's need for more COVID-19 clinical trials. Makoni M Lancet; 2021 May; 397(10289):2037. PubMed ID: 34062137 [No Abstract] [Full Text] [Related]
8. COVID-19 and changes in the National Immunisation Program: a unique opportunity to optimise the Australian Immunisation Register (AIR). Tuckerman J; Blyth CC; Beard FH; Danchin MH Med J Aust; 2021 Apr; 214(6):247-249.e1. PubMed ID: 33745151 [No Abstract] [Full Text] [Related]
9. [Fight against COVID-19: market overview and pipeline of ongoing trials]. Pontremoli R; Richard G; Vuddamalay G; Groux N Med Sci (Paris); 2020 Dec; 36(12):1225-1232. PubMed ID: 33211647 [No Abstract] [Full Text] [Related]
10. New vaccine production platforms used in developing SARS-CoV-2 vaccine candidates. Ura T; Yamashita A; Mizuki N; Okuda K; Shimada M Vaccine; 2021 Jan; 39(2):197-201. PubMed ID: 33279318 [TBL] [Abstract][Full Text] [Related]
11. What Are COVID-19 Vaccines? Hartert TV; Sockrider M Am J Respir Crit Care Med; 2021 May; 203(9):P22-P23. PubMed ID: 33759735 [No Abstract] [Full Text] [Related]
12. Early rate reductions of SARS-CoV-2 infection and COVID-19 in BNT162b2 vaccine recipients. Amit S; Regev-Yochay G; Afek A; Kreiss Y; Leshem E Lancet; 2021 Mar; 397(10277):875-877. PubMed ID: 33610193 [No Abstract] [Full Text] [Related]
13. Completion of clinical trials in light of COVID-19. Burki TK Lancet Respir Med; 2020 Dec; 8(12):1178-1180. PubMed ID: 33010809 [No Abstract] [Full Text] [Related]
14. Tanzania's position on the COVID-19 pandemic. Mfinanga SG; Mnyambwa NP; Minja DT; Ntinginya NE; Ngadaya E; Makani J; Makubi AN Lancet; 2021 Apr; 397(10284):1542-1543. PubMed ID: 33864748 [No Abstract] [Full Text] [Related]
15. From COVID-19 to COVID-20: One Virus, Two Diseases. James JJ Disaster Med Public Health Prep; 2020 Dec; 14(6):e18-e20. PubMed ID: 33019951 [No Abstract] [Full Text] [Related]
17. The race for a COVID-19 vaccine. Lavigne SE Can J Dent Hyg; 2020 Oct; 54(3):107-109. PubMed ID: 33240370 [No Abstract] [Full Text] [Related]
18. COVID-19 human challenge studies in the UK. Kirby T Lancet Respir Med; 2020 Dec; 8(12):e96. PubMed ID: 33137284 [No Abstract] [Full Text] [Related]
19. SARS-CoV-2 Vaccines: Much Accomplished, Much to Learn. Connors M; Graham BS; Lane HC; Fauci AS Ann Intern Med; 2021 May; 174(5):687-690. PubMed ID: 33460347 [TBL] [Abstract][Full Text] [Related]
20. [In subjects 16 years of age and older, is messenger RNA vaccine BNT162b2 against COVID-19 effective and safe?]. Lanthier L; Carignan A; Plourde MÉ; Cauchon M Rev Med Interne; 2021 Mar; 42(3):227-228. PubMed ID: 33612319 [No Abstract] [Full Text] [Related] [Next] [New Search]